BioBucksSubscribe
HomeDaily TapeResearch HubAboutSubscribe
Join 2,000+ investors

The biotech deal tape in your inbox. Free.

  • ✓Top news, M&A, BD&L, IPOs and VC — every morning
  • ✓Deal economics with investor-grade context
  • ✓Research Hub access: live trackers updated weekly
  • ✓5 minutes. Published every weekday.
Recent editions
Jun 17, 2026
Wednesday: Moderna's flu do-over, and the AI-deal machine hums
Moderna faces the FDA panel, Lilly grabs more pain, and Merck writes another AI check.
Jun 16, 2026
Tuesday: CRISPR's one-shot moment, Neumora's three-strike out
Intellia rewrites HAE, Spyre stokes TL1A takeout math, and Neumora cuts a third of staff.
Jun 15, 2026
Monday: J&J's Talvey posts a 72% myeloma edge
J&J leads on Phase 3 myeloma, Sanofi expands Tzield, and Lilly adds a CLL win as biotech stays bid.
BioBucks
Daily TapeResearch HubAboutSubscribePrivacy
© 2026 BioBucks